Perspectives on Chemical & Life Sciences
7 total results. Page 1 of 1.
Personalized medicine patent claims have been under assault since the Supreme Court’s Mayo v. Prometheus decision.
This year brought us very significant changes in patent jurisprudence from the Supreme Court and Federal Circuit affecting Chemical & Life Sciences patent practice.
On April 28, Arent Fox LLP attorney Alexander H. Spiegler secured a final written decision in favor of Gowan Company.
As in previous years, 2016 brought us a combination of both expected and unexpected holdings by the Supreme Court and the Federal Circuit.
Arent Fox filed an amici brief on behalf of the Wisconsin Alumni Research Foundation, the Indiana University Research and Technology Corporation, and San Diego Intellectual Property Law Association. Our brief focused on the following three errors in the Federal Circuit’s rationale.
As in previous years, 2015 brought a combination of expected and unexpected holdings by the Supreme Court and the Federal Circuit.
Arent Fox Intellectual Property partner Marylee Jenkins was quoted in numerous news outlets following her oral argument before the Supreme Court of the United States yesterday in a case over the legality of patenting human genes.